Low molecular weight heparin treatment for malignant melanoma: a pilot clinical trial.
Wojtukiewicz
M Z
MZ
Kozlowski
L
L
Ostrowska
K
K
Dmitruk
A
A
Zacharski
L R
LR
D000925:Anticoagulants / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002330:Carmustine / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage; D017984:Enoxaparin / Q000627:therapeutic use*; D005240:Feasibility Studies; D006025:Glycosaminoglycans / Q000502:physiology; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D009367:Neoplasm Staging; D010865:Pilot Projects; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D016019:Survival Analysis; D013629:Tamoxifen / Q000008:administration & dosage; D016896:Treatment Outcome
D000925:Anticoagulants; D000970:Antineoplastic Agents; D017984:Enoxaparin; D006025:Glycosaminoglycans; D013629:Tamoxifen; D003606:Dacarbazine; D002945:Cisplatin; D002330:Carmustine